Furthermore, ARHGAP4 is associated with immune cells (B, CD8+ and CD4+ T, macrophages, neutrophils, and dendritic cells) and may be a potential biomarker for the prognosis of CRC (34). Here, CD8A is linked to colorectal carcinoma.